Latest Update on Planning for NIH's Clinical Trial of Cyclodextrin
~ November 2012 ~
Cyclodextrin (HP-β-CD) for NPC1 Disease
~ Clinical Strategy ~
Nuria Carrillo, MD
Therapeutics for Rare and Neglected Diseases (TRND)
National Institutes of Health ~ Bethesda, MD
Cyclodextrin (HP-β-CD) for NPC1 Disease ~ Clinical Strategy ~
Created and presented by:
Nuria Carrillo, MD; Staff Clinician
Therapeutics for Rare and Neglected Diseases (TRND)
Division of Preclinical Innovation
National Center for Advancing Translational Sciences
National Institutes of Health ~ Bethesda, MD